In contrast, CML cell lines were relatively insensitive to single S63845 treatment, a finding suggested to be linked to their consistently high BCL-xL levels [10]. The gene discussed is BCL2L1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.